Motivational Interviewing to Prevent Suicide in High Risk Veterans

Not Applicable

Completed

• Conditions: Treatment Engagement; Suicidal Ideation
• Interventions: Behavioral: MI-SI-R+TAU; Other: TAU Alone; Behavioral: MI-SI+TAU

• Registration Number: NCT01544127
• Lead Sponsor: VA Office of Research and Development

Brief Summary

The purpose of study is to test the efficacy of an adaptation of Motivational Interviewing to Address Suicidal Ideation (MI-SI) on the severity of suicidal ideation in psychiatrically hospitalized Veterans at high risk for suicide.

Detailed Description

Veterans who receive health care from the VA are at elevated risk for suicide, and the number of Veterans at high risk may be growing. Although the months following discharge from psychiatric hospitalization are a period of acute risk for Veterans, there is a dearth of empirically supported treatments tailored to psychiatric inpatients and no studies examining treatments for psychiatrically hospitalized Veterans. This randomized controlled trial will test the efficacy of an adaptation of Motivational Interviewing to Address Suicidal Ideation (MI-SI) on the severity of suicidal ideation in psychiatrically hospitalized Veterans at high risk for suicide. Participants will be recruited from the Acute Psychiatric Inpatient Unit at the Syracuse VA Medical Center. To meet high-risk criteria, Veterans must score over two on the Scale for Suicidal Ideation (SSI), which is prospectively predictive of death by suicide. Participants will complete a screening assessment to confirm eligibility and a baseline assessment of risk factors for suicide. They will be randomized to receive Motivational Interviewing to Address Suicidal Ideation (MI-SI) or a revised version (MI-SI-R) plus treatment as usual (TAU), or TAU alone. The MI-SI groups will receive two sessions of MI-SI during hospitalization and one telephone booster session after discharge. Participants in all conditions will be asked to complete telephone follow-up interviews at 1, 3, and 6 months after discharge. Change in the severity of suicidal ideation will be measured using the SSI.

Basic Information
|
Recruitment & Eligibility
|
Study & Design
|
Trial Locations

Study Timeline

• Study First Submitted: 2012-02-28
• Study First Submitted QC: 2012-03-02
• Study First Posted: 2012-03-05
• Study Start: 2012-07-30
• Primary Completion: 2017-12-05
• Study Completion: 2017-12-05
• Results First Submitted: 2019-03-19
• Results First Submitted QC: 2019-07-31
• Results First Posted: 2019-09-11
• Status Verified: 2022-02
• Last Update Submitted: 2022-02-23
• Last Update Posted: 2022-02-25

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 132

Inclusion Criteria

• Veteran status,
• admitted to psychiatric inpatient unit,
• age 18 and over,
• English speaking,
• able to understand the study and provide informed consent,
• clinically cleared to participate by unit staff,
• receive health care from a VHA facility in upstate New York
• at increased risk for suicide (Scale for Suicidal Ideation [SSI] > 2)

Read More

Exclusion Criteria

• current psychosis,
• current mania,
• dementia,
• prisoner status,
• being inaccessible
• being discharged from the unit less than 48 hours after being identified by study staff

Read More

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
MI-SI-R+TAU	MI-SI-R+TAU	Motivational Interviewing to Address Suicidal Ideation Revised
TAU Alone	TAU Alone	Treatment as usual
MI-SI+TAU	MI-SI+TAU	Motivational Interviewing to Address Suicidal Ideation

Primary Outcome Measures

Name	Time	Method
Number of Participants With Suicidal Ideation	6 months	The number of participants with suicidal ideation and severity of suicidal ideation was measured using the Scale for Suicidal Ideation (SSI) at 1, 3, and 6 months after discharge. Scores range from 0-38, with scores of 1 or greater indicating the presence of suicidal ideation.
Severity of Suicidal Ideation Among Those With It	6 months	Severity of suicidal ideation was measured by the Scale for Suicidal Ideation at 1, 3, and 6 months after discharge. Scores range from 0 to 38, with higher scores indicating more severe suicidal ideation.

Secondary Outcome Measures

Name	Time	Method
Number of Participants With Two Outpatient Mental Health or Substance Treatment Sessions	1 month	Treatment engagement was measured using the Treatment Services Review-6 (TSR-6) at 1 month after discharge.

Trial Locations

Locations (1)

Syracuse VA Medical Center, Syracuse, NY; 🇺🇸 Syracuse, New York, United States